Trial intelligence / Profile preview

Thorough QT/QTc study of inhaled ADASUVE in healthy volunteers

NL-OMON38911Active, not recruiting

Sponsor: Alexza Pharmaceuticals Inc
Start: May 2013
Modality: Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries: 1

Overview

Randomised trial in agitation comparing ADASUVE arm, Placebo arm and Moxifloxacin positive-control arm (3 arms). Primary endpoints: Plasma concentrations, Pharmacokinetic parameters and 5 more. Started May 2013; status: active, not recruiting.

Drugs

loxapinemoxifloxacin

Conditions

agitation

Beyond the preview

Go deeper on NL-OMON38911.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38911.